An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

BACKGROUND: In ovarian cancer, the reported rate of EGFR expression varies between 4-70% depending on assessment method and data on patient outcome are conflicting. Methods: In this study we investigated EGFR expression and its prognostic value in a cohort of 121 invasive ovarian carcinomas, using a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Noske, Aurelia, Schwabe, Michael, Weichert, Wilko, Darb-Esfahani, Silvia, Buckendahl, Ann-Christin, Sehouli, Jalid, Braicu, Elena I, Budczies, Jan, Dietel, Manfred, Denkert, Carsten
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3149030/
https://ncbi.nlm.nih.gov/pubmed/21756326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-294
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires